Brazaves miglustat regulatory update

Japan's Ministry of Health, Labor and Welfare (MHLW) approved Actelion's Brazaves miglustat to treat Niemann-Pick type C disease. Miglustat is marketed as Zavesca for the indication in 42 countries i...